Skip to main content

Tuberculosis: Medical Treatments

Volume 475: debated on Tuesday 6 May 2008

To ask the Secretary of State for Health what support his Department has allocated to developing more effective treatments for drug-resistant tuberculosis. (203364)

Drug-resistant tuberculosis (TB) arises mostly from either poor or incomplete previous treatment of TB. The key to tackling drug resistance is to prevent it developing in the first place, and our strategy is focused on strengthening national health service TB services to improve early case detection and completion of treatment.

The TB Toolkit launched last year provides models of best practice for the national health service to deliver TB services. We have also funded the British Thoracic Society to establish a clinical advisory network to advise on treatment of drug-resistant cases. We are also funding work to raise awareness of TB among health care professionals and groups at higher risk of TB.